Published in Ann Intern Med on April 01, 1977
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax (1987) 1.90
Immunodiagnosis of aspergillosis. Clin Microbiol Rev (1991) 1.90
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol (2006) 1.54
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38
Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis. J Clin Microbiol (1999) 1.27
Allergic bronchopulmonary fungal disease without clinical asthma. Thorax (1981) 1.26
Eosinophilic pneumonias. Clin Microbiol Rev (2012) 1.20
Pulmonary eosinophilia with and without allergic bronchopulmonary aspergillosis. Thorax (1989) 1.19
Rise in total IgE as an indicator of allergic bronchopulmonary aspergillosis in cystic fibrosis. Thorax (1994) 1.17
Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg (1983) 1.15
Pathogenesis and management of aspergillosis in cystic fibrosis. Arch Dis Child (1990) 1.10
Lung collapse caused by allergic bronchopulmonary aspergillosis in non-asthmatic patients. Br Med J (Clin Res Ed) (1982) 1.07
Co-clustering phenome-genome for phenotype classification and disease gene discovery. Nucleic Acids Res (2012) 1.05
Aspergillus in the lung: diverse and coincident forms. Eur Radiol (2003) 1.04
Impact of Aspergillus fumigatus in allergic airway diseases. Clin Transl Allergy (2011) 1.03
Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy (2014) 1.03
Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun (1998) 0.99
Antibody response to low-molecular-weight antigens of Aspergillus fumigatus in allergic bronchopulmonary aspergillosis. J Clin Microbiol (1989) 0.99
Diagnostic performance of various tests and criteria employed in allergic bronchopulmonary aspergillosis: a latent class analysis. PLoS One (2013) 0.98
Aspergillus fumigatus-specific antibodies in allergic bronchopulmonary aspergillosis and aspergilloma: evidence for a polyclonal antibody response. J Clin Microbiol (1987) 0.97
Allergic bronchopulmonary aspergillosis: a review. J R Soc Med (1992) 0.95
An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One (2010) 0.95
Influence of age and disease severity on high resolution CT lung densitometry in asthma. Thorax (2001) 0.94
Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int (2013) 0.91
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1. Clin Exp Allergy (2012) 0.89
Recombinant expression and antigenic properties of a 32-kilodalton extracellular alkaline protease, representing a possible virulence factor from Aspergillus fumigatus. Infect Immun (1994) 0.89
Allergic bronchopulmonary aspergillosis coupled with broncholithiasis in a non-asthmatic patient. J Korean Med Sci (2007) 0.86
Allergic bronchopulmonary stemphyliosis. Thorax (1980) 0.85
Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi. Yale J Biol Med (2007) 0.84
Allergic Bronchopulmonary Aspergillosis: A Perplexing Clinical Entity. Allergy Asthma Immunol Res (2016) 0.83
Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun (1999) 0.82
Chest radiographic and computed tomographic manifestations in allergic bronchopulmonary aspergillosis. World J Radiol (2012) 0.82
Allergic bronchopulmonary mycosis due to co-infection with Aspergillus fumigatus and Schizophyllum commune. IDCases (2014) 0.80
Atypical Presentation of Allergic Bronchopulmonary Aspergillosis: An Unusual Cause of Difficult-to-Treat Asthma. J Family Med Prim Care (2013) 0.80
Precipitins and specific IgG antibody to Aspergillus fumigatus in a chest unit population. Thorax (1992) 0.79
Lymphocyte sensitization to Aspergillus fumigatus in allergic bronchopulmonary aspergillosis. Clin Exp Immunol (1989) 0.79
A favorable clinical effect of an expectorant in allergic bronchopulmonary mycosis caused by Schizophyllum commune. Respir Med Case Rep (2016) 0.78
Difficult-to-control asthma management through the use of a specific protocol. Clinics (Sao Paulo) (2010) 0.78
Miliary nodules: An unusual presentation of allergic bronchopulmonary aspergillosis. Lung India (2014) 0.78
Aspergillosis. J R Soc Med (1992) 0.78
Treatment of Allergic Bronchopulmonary Aspergillosis with Fluconazole and Itraconazole. Med J Armed Forces India (2011) 0.78
Two cases of non-cystic fibrosis (CF) bronchiectasis with allergic bronchopulmonary aspergillosis. Respir Med Case Rep (2016) 0.78
Allergic bronchopulmonary aspergillosis in a 9-year-old boy. Eur J Pediatr (2002) 0.77
Role of C-terminal cysteine residues of Aspergillus fumigatus allergen Asp f 4 in immunoglobulin E binding. Clin Diagn Lab Immunol (2004) 0.76
Clinical features of allergic bronchopulmonary aspergillosis in Korea. Allergy Asthma Immunol Res (2012) 0.76
Allergic bronchopulmonary candidiasis. Med J Armed Forces India (2012) 0.75
Childhood allergic bronchopulmonary aspergillosis presenting as a middle lobe syndrome. Asia Pac Allergy (2016) 0.75
Vanishing lung mass in a patient with asthma. J Thorac Dis (2013) 0.75
Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan. BMJ Open Respir Res (2016) 0.75
Allergy-epitomes of progress: allergic bronchopulmonary aspergillosis. West J Med (1978) 0.75
Rarer infectious diseases. Can Fam Physician (1980) 0.75
Diagnosing allergic bronchopulmonay aspergillosis. Br Med J (1977) 0.75
Allergic and invasive aspergillosis. J R Soc Med (1995) 0.75
Beyond bronchitis: a review of the congenital and acquired abnormalities of the bronchus. Insights Imaging (2016) 0.75
Allergic bronchopulmonary aspergillosis presenting with a pulmonary mass mimicking lung cancer. Respirol Case Rep (2013) 0.75
Exophiala pisciphila: a novel cause of allergic bronchopulmonary mycosis. J Thorac Dis (2016) 0.75
Prevalence of Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with bronchial asthma at a tertiary care center in North India. Lung India (2017) 0.75
Mass like lesions disappearing with treatment in a young patient. Indian J Med Res (2015) 0.75
Coexistence of allergic bronchopulmonary aspergillosis and allergic aspergillus sinusitis in a patient without clinical asthma. BMJ Case Rep (2013) 0.75
Allergic bronchopulmonary aspergillosis. West J Med (1979) 0.75
Allergic bronchopulmonary aspergillosis presenting as chronic cough in an elderly woman without previously documented asthma. Perm J (2013) 0.75
Uncontrolled asthma and recurring pulmonary opacities: just asthma? BMJ Case Rep (2014) 0.75
Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: prevalence and percentage of positive tests in the employed diagnostic criteria. Eur J Epidemiol (2000) 0.75
A review of 42 asthmatic children with allergic bronchopulmonary aspergillosis. Asia Pac Allergy (2017) 0.75
Regulatory sequences involved in the promotion and termination of RNA transcription. Annu Rev Genet (1979) 54.83
Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev (2001) 9.14
A system to study promoter and terminator signals recognized by Escherichia coli RNA polymerase. Gene Amplif Anal (1981) 8.21
Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. BMJ (1996) 6.31
Patients evaluate their hospital care: a national survey. Health Aff (Millwood) (1991) 5.44
Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science (2001) 5.40
The relationship between function and DNA sequence in an intercistronic regulatory region in phage lambda. Nature (1978) 5.38
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet (1995) 5.02
Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature (1990) 4.81
The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity. Nature (1984) 4.61
Purified lambda regulatory protein cII positively activates promoters for lysogenic development. Nature (1981) 4.60
Termination of transcription in E. coli. Cell (1983) 4.42
Efficient expression of Escherichia coli galactokinase gene in mammalian cells. Proc Natl Acad Sci U S A (1982) 4.25
Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem (1992) 4.22
Efficient translation of prokaryotic mRNAs in a eukaryotic cell-free system requires addition of a cap structure. Nature (1979) 4.11
Plasmid-mediated beta-lactamase production in Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 4.02
The use of pKc30 and its derivatives for controlled expression of genes. Methods Enzymol (1983) 3.90
Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem (1998) 3.88
Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells. Cell (1984) 3.81
Molecular characterization of two beta-lactamase-specifying plasmids isolated from Neisseria gonorrhoeae. J Bacteriol (1977) 3.76
Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. Proc Natl Acad Sci U S A (1987) 3.72
Termination of transcription in bacteriophage lambda. Heterogeneous, 3'-terminal oligo-adenylate additions and the effects of rho factor. J Biol Chem (1975) 3.71
Conjugal transfer of R plasmids in Neisseria gonorrhoeae. Nature (1977) 3.71
Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia. Anesthesiology (1996) 3.65
Surveillance and prevention of residential-fire injuries. N Engl J Med (1996) 3.60
Translational coupling at an intercistronic boundary of the Escherichia coli galactose operon. Cell (1982) 3.56
Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A (1989) 3.55
A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol (2000) 3.50
The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch Intern Med (1999) 3.33
Highly reiterated sequences of SIMIANSIMIANSIMIANSIMIANSIMIAN. Science (1978) 3.29
Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A (1984) 3.25
Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol (1985) 3.24
Constitutive function of a positively regulated promoter reveals new sequences essential for activity. J Biol Chem (1987) 3.23
The momentum of human behavior in a natural setting. J Exp Anal Behav (1990) 3.13
Allergic reactions to insulin. JAMA (1971) 3.11
Role of adherence in growth of Acinetobacter calcoaceticus RAG-1 on hexadecane. J Bacteriol (1981) 2.96
gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science (2000) 2.90
The ecology of gonococcal plasmids. J Gen Microbiol (1979) 2.87
Nucleotide sequence homology at the 3' termini of RNA from vesicular stomatitis virus and its defective interfering particles. Proc Natl Acad Sci U S A (1978) 2.82
Sequence of Cro gene of bacteriophage lambda. Nature (1977) 2.78
Factors predictive of stroke outcome in a rehabilitation setting. Neurology (1996) 2.78
Copper metallothionein of yeast, structure of the gene, and regulation of expression. Proc Natl Acad Sci U S A (1984) 2.74
Adherence of Acinetobacter calcoaceticus RAG-1 to human epithelial cells and to hexadecane. Infect Immun (1981) 2.74
Bacterial adherence to polystyrene: a replica method of screening for bacterial hydrophobicity. Appl Environ Microbiol (1981) 2.73
E1A 13S and 12S mRNA products made in Escherichia coli both function as nucleus-localized transcription activators but do not directly bind DNA. Mol Cell Biol (1985) 2.68
The alternative sigma factor, sigmaE, is critically important for the virulence of Salmonella typhimurium. Infect Immun (1999) 2.67
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci U S A (1995) 2.63
Endocytosis in Chang liver cells. Quantitation by sucrose- 3 H uptake and inhibition by cytochalasin B. J Cell Biol (1971) 2.63
A rho-dependent termination site in the gene coding for tyrosine tRNA su3 of Escherichia coli. Nature (1978) 2.58
Affecting gene expression by altering the length and sequence of the 5' leader. Proc Natl Acad Sci U S A (1984) 2.58
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Nucleotide sequence of the operator-promoter region of the galactose operon of Escherichia coli. Proc Natl Acad Sci U S A (1977) 2.57
Microinjected c-myc as a competence factor. Science (1985) 2.56
Evolution of two-component signal transduction. Mol Biol Evol (2000) 2.55
Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc Natl Acad Sci U S A (1991) 2.54
Identification, evolution, and essentiality of the mevalonate pathway for isopentenyl diphosphate biosynthesis in gram-positive cocci. J Bacteriol (2000) 2.50
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49
Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41
Adenovirus E1a gene product expressed at high levels in Escherichia coli is functional. Science (1984) 2.38
Structure and function of the cy control region of bacteriophage lambda. J Mol Biol (1980) 2.37
A promoter of pBR322 activated by cAMP receptor protein. Nucleic Acids Res (1981) 2.37
Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer (1987) 2.35
Pentapeptide nuclear localization signal in adenovirus E1a. Mol Cell Biol (1987) 2.30
Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol (1996) 2.30
The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med (1994) 2.23
Promoter for the establishment of repressor synthesis in bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 2.23
Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood (2001) 2.21
Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19
Munchausen's stridor: non-organic laryngeal obstruction. Clin Allergy (1974) 2.19
Removal of a terminator structure by RNA processing regulates int gene expression. J Mol Biol (1984) 2.13
Bacteriophage lambda protein cII binds promoters on the opposite face of the DNA helix from RNA polymerase. Nature (1983) 2.13
Nucleotide sequences of the 5' and 3' termini of bacteriophage T7 early messenger RNAs synthesized in vivo: evidence for sequence specificity in RNA processing. J Mol Biol (1974) 2.10
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem (1994) 2.04
D'oh! An analysis of the medical care provided to the family of Homer J. Simpson. CMAJ (1998) 2.04
The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med (1990) 2.03
Stevens-Johnson syndrome: getting ready for the year 2000 and beyond. Ann Allergy Asthma Immunol (1999) 2.01
The expression in yeast of the Escherichia coli galK gene on CYC1::galK fusion plasmids. Gene (1983) 1.98
Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci (1988) 1.98
Characterization of short tandem repeats from thirty-one human telomeres. Genome Res (1997) 1.96
Identification of the small subunit of ribulose 1,5-bisphosphate carboxylase as a product of wheat leaf cytoplasmic ribosomes. Arch Biochem Biophys (1976) 1.95
Functions of purified E1A protein microinjected into mammalian cells. Proc Natl Acad Sci U S A (1984) 1.92
Employee assistance programmes. Occup Med (Lond) (1994) 1.92
Synthesis of the complete trans-activation gene product of human T-lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci U S A (1986) 1.90
The acquired immunodeficiency syndrome in Australia: incidence 1982-1991. Med J Aust (1993) 1.89
Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J Bacteriol (1999) 1.88
Differential translation efficiency explains discoordinate expression of the galactose operon. Cell (1981) 1.87
Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun (2002) 1.87
Activation of human immunodeficiency virus type 1 by DNA damage in human cells. Nature (1988) 1.85
The 289-amino acid E1A protein of adenovirus binds zinc in a region that is important for trans-activation. Proc Natl Acad Sci U S A (1988) 1.84
Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression. Infect Immun (1994) 1.79
Two promoters, one inducible and one constitutive, control transcription of the Streptomyces lividans galactose operon. Proc Natl Acad Sci U S A (1987) 1.79
The nucleotide sequence of the tetracycline resistance determinant tetM from Ureaplasma urealyticum. Nucleic Acids Res (1988) 1.77
Purification and characterization of human H-ras proteins expressed in Escherichia coli. Mol Cell Biol (1985) 1.77
Impaired nuclear transport of a human variant tRNAiMet. Nature (1982) 1.75
A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. J Clin Invest (1996) 1.74
Inhibition of bacterial adherence to hydrocarbons and epithelial cells by emulsan. Infect Immun (1983) 1.71
Trimellitic anhydride-induced airway syndromes: clinical and immunologic studies. J Allergy Clin Immunol (1977) 1.71
National Ignition Facility laser performance status. Appl Opt (2007) 1.70
Structure of the human oestrogen-responsive gene pS2. Nucleic Acids Res (1987) 1.70